VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML.
Saved in:
| Title: | VINCENT: A randomized-controlled trial evaluating venetoclax plus azacitidine versus intensive chemotherapy in patients with newly diagnosed, NPM1-mutated AML. |
|---|---|
| Authors: | Kretschmer, Lydia1 (AUTHOR) lydia.kretschmer@ukdd.de, Ruhnke, Leo1 (AUTHOR), Schliemann, Christoph2 (AUTHOR), Fransecky, Lars3 (AUTHOR), Steffen, Björn4 (AUTHOR), Kaufmann, Martin5 (AUTHOR), Burchert, Andreas6 (AUTHOR), Schmid, Christoph7 (AUTHOR), Hanoun, Maher8 (AUTHOR), Sauer, Tim9 (AUTHOR), Metzeler, Klaus H.10 (AUTHOR), Schäfer-Eckart, Kerstin11 (AUTHOR), Hänel, Mathias12 (AUTHOR), Crysandt, Martina13 (AUTHOR), Jäger, Paul14 (AUTHOR), Krause, Stefan W.15 (AUTHOR), Dierks, Christine16 (AUTHOR), Klein, Stefan17 (AUTHOR), Maguire, Nadia18 (AUTHOR), Frenzel, Lukas P.19 (AUTHOR) |
| Source: | Annals of Hematology. Jul2025, Vol. 104 Issue 7, p3647-3654. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
